REQUEST A DEMO
Total
USD $0.00
Search more companies

Novmetapharma Co. Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Novmetapharma Co. Ltd. Profile Updated: June 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Novmetapharma Co. Ltd. is an enterprise located in South Korea, with the main office in Seoul. It operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on April 13, 2026. Novmetapharma Co. Ltd. currently employs 20 (2024) people. There was a net sales revenue increase of 227.16% reported in Novmetapharma Co. Ltd.’s latest financial highlights for 2024. Over the same period, its total assets decreased by 49.94%. In 2024, Novmetapharma Co. Ltd.’s net profit margin increased by 78276.41%.

Headquarters
Trees Bldg., 727, Eonju-Ro, Gangnam-Gu
Seoul; Seoul;

Contact Details: Purchase the Novmetapharma Co. Ltd. report to view the information.

Website: http://www.novmeta.com

Basic Information
Total Employees:
Purchase the Novmetapharma Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the Novmetapharma Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Novmetapharma Co. Ltd. report to view the information.
Incorporation Date:
April 13, 2026
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Subsidiaries
주식회사 노브메타헬스
55.6%
Company Performance
Financial values in the chart are available after Novmetapharma Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
227.16%
Total Operating Revenue
204.72%
Operating Profit
28.73%
EBITDA
29.97%
Net Profit/Loss for the Period
55.36%
Total Assets
-49.94%
Total Equity
-68.48%
Operating Profit Margin
43894.99%
Net Profit Margin
78276.41%
Return on Equity (ROE)
-93.74%
Debt / Equity
12.13%
Quick Ratio
-1.57%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?